Terumo's Interventional Systems division is a global leader in cardiovascular care, providing low invasive devices for the treatment of coronary artery disease. Our philosophy is to deliver high quality devices with unique and innovative technology. We offer a comprehensive device portfolio including products for the diagnosis and treatment of coronary artery disease.
Terumo develops products for interventional radiologists that specialize in treating patients with oncological indications. Rising to the challenge of creating innovative treatments for patients, we bring you a complete range of interventional oncology products that focus on Access, Loco-regional treatments and Endovascular embolization.
Our vision is to become the pioneer and vendor of choice in the region, delivering state-of-the-art medical devices with superior integrity and professionalism.
Abbott's CardioValvs portfolio includes mechanical and bioprosthetic heart valves designed for aortic and mitral valve replacement procedures. These devices, such as the Regent™ mechanical valve and Epic™ tissue valve, are known for their proven hemodynamic performance, durability, and ease of implantation.
Abbott's Structural Intervention portfolio features the Amplatzer™ line of occluder, designed for minimally invasive closure of structural heart congenital defects. The Amulet™ LAA Occluder offers stroke risk reduction in patients with non-valvular atrial fibrillation, providing a dual-seal mechanism for complete closure.
Abbott's latest-generation valve platform designed to treat severe aortic stenosis with a minimally invasive approach. It features the Navitor Vision™ valve, which provides exceptional sealing performance, hemodynamics, and deliverability, even in complex anatomies.
Innovation is at the heart of Robocath’s strategy, making R-One+™ a unique solution, protected by over 60 international patents.
This robotic assistance platform was designed using a global approach to the needs of interventional cardiology. It integrates flawlessly with the interventional protocol, providing physicians with reliable, precise assistance during procedures and enhancing movements for better interventional conditions, in particular by being totally protected from x-rays.
The Paradise® System by ReCor Medical is a next-generation, minimally invasive solution for managing uncontrolled hypertension. The system uses high-frequency ultrasound energy delivered via a balloon catheter to denervate renal nerves, targeting the sympathetic nervous system without damaging the arterial wall.
STEREOTAXIS is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.
The RESTORE® DEB is a Paclitaxel-coated PTCA balloon catheter developed by Cardionovum, engineered for treating coronary in-stent restenosis and small vessel disease. It delivers a targeted anti-proliferative drug directly to the arterial wall without the need for a permanent implant.
